[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334979-105":59,"doc-detail-334979-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-of-the-plasma-membrane-citrate-carrier-pmcic-in-human-cancerous-tissuescorrelation-with-tumour-aggressiveness","Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness","","Cancer cells rely on heightened metabolic activity to sustain rapid proliferation and metastatic behavior, for which extracellular citrate becomes crucial. This study evaluates expression of the plasma membrane citrate carrier (pmCiC) alongside markers of stromal activation and angiogenesis (FAP and CD31) across human cancer tissues from diverse origins. No correlation emerges between disease stage and FAP or CD31, whereas pmCiC expression correlates with tumour stage in cancer cells and supporting stroma, increasing in later disease and metastatic sites, supporting prognostic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-the-plasma-membrane-citrate-carrier-pmcic-in-human-cancerous-tissuescorrelation-with-tumour-aggressiveness/334979/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-the-plasma-membrane-citrate-carrier-pmcic-in-human-cancerous-tissuescorrelation-with-tumour-aggressiveness/334979.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study investigate regarding pmCiC in cancer tissues?","Question",{"text":112,"@type":113},"It evaluates pmCiC expression in human cancer tissues and compares it with stromal and angiogenesis markers to assess relationships with tumour aggressiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What relationship was found between pmCiC expression and tumour stage?",{"text":117,"@type":113},"pmCiC expression in cancer cells and cancer-associated stroma correlates with tumour stage, increasing at later development stages, especially at metastatic sites.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is extracellular citrate important for cancer cells in this context?",{"text":121,"@type":113},"Extracellular citrate supports cancer cell metabolism, including fatty acid synthesis, mitochondrial activity, protein synthesis, and histone acetylation, and can promote a metastatic phenotype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334979,1790221420,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Original Research PUBLISHED 03 July 2024  \nDOI 10.3389/fcell.2024.1308135  \nOPEN ACCESS  \nEDITED BY  \nBrunie H. Felding,  \nThe Scripps Research Institute, United States  \nREVIEWED BY  \nThekla Cordes,  \nTechnical University of Braunschweig, Germany Ellen Ackerstaff,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nPiyarat Srisawang,  \nNaresuan University, Thailand Johann Matschke,  \nEssen University Hospital, Germany  \n*CORRESPONDENCE  \nBarbara Schwertner,  \n [barbara.schwertner@ukr.de](barbara.schwertner@ukr.de)[ ](barbara.schwertner@ukr.de)Andreas Gaumann,  \n andreas. gaumann@pathologie[kaufbeuren.de](kaufbeuren.de)  \n‡PRESENT ADDRESS  \nMaria E. Mycielska,  \nMetaSMIte, Sp. z o.o., Krakow, Poland  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 05 October 2023  \nACCEPTED 17 June 2024  \nPUBLISHED 03 July 2024  \nCITATION  \nSchwertner B, Dahdal G, Jagla W, Grossmann L, Drexler K, Krahn MP, Evert K, Berneburg M, Haferkamp S, Ziegler C, Parkinson EK, Zahn G, Mycielska ME and Gaumann A (2024), Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous  \ntissues—correlation with tumour aggressiveness.  \nFront. Cell Dev. Biol. 12:1308135 .  \ndoi: 10.3389/fcell.2024.1308135  \nCOPYRIGHT  \n© 2024 Schwertner, Dahdal, Jagla, Grossmann, Drexler, Krahn, Evert, Berneburg, Haferkamp, Ziegler, Parkinson, Zahn, Mycielska and Gaumann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExpression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness  \nBarbara Schwertner 1*†, George Dahdal 1†, Wolfgang Jagla 2, Luis Grossmann 3, Konstantin Drexler 1, Michael P. Krahn 4, Katja Evert 5, Mark Berneburg 1, Sebastian Haferkamp 1, Christine Ziegler 3, Eric K. Parkinson 6, Grit Zahn 7,  \nMaria E. Mycielska 3‡ and Andreas Gaumann 2*  \n1Department of Dermatology, University Hospital Regensburg, Regensburg, Germany, 2 Institute of Pathology Kaufbeuren-Ravensburg, Kaufbeuren, Germany, 3 Department of Structural Biology, Institute of Biophysics and Physical Biochemistry, University of Regensburg, Regensburg, Germany, 4 Medical Cell Biology, Internal Medicine D, University Hospital Münster, Münster, Germany, 5 Institute of Pathology, University of Regensburg, Regensburg, Germany, 6Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 7 Eternygen GmbH, Berlin, Germany  \nWe have recently shown that cancer cells of various origins take up extracellular citrate through the plasma membrane citrate carrier (pmCiC), a speciﬁc plasma membrane citrate transporter. Extracellular citrate is required to support cancer cell metabolism, in particular fatty acid synthesis, mitochondrial activity, protein synthesis and histone acetylation . In addition, cancer cells tend to acquire a metastatic phenotype in the presence of extracellular citrate. Our recent study also showed that cancer-associated stromal cells synthesise and release citrate and that this process is controlled by cancer cells. In the present study, we evaluated the expression of pmCiC, ﬁbroblast activation protein-α (FAP) and the angiogenesis marker cluster of differentiation 31 (CD31) in human cancer tissues of different origins. In the cohort studied, we found no correlation between disease stage and the expression of FAP or CD31 . However, we have identiﬁed a clear correlation between pmCiC expression in cancer cells and cancer-associated s","cbCaiaPnDo4TjSVr","https://ap.wps.com/l/cbCaiaPnDo4TjSVr","pdf",3377314,11,"English","# Introduction\n## Cancer metabolism and citrate dependence\n## Role of pmCiC in citrate uptake","[{\"question\":\"What does the study investigate regarding pmCiC in cancer tissues?\",\"answer\":\"It evaluates pmCiC expression in human cancer tissues and compares it with stromal and angiogenesis markers to assess relationships with tumour aggressiveness.\"},{\"question\":\"What relationship was found between pmCiC expression and tumour stage?\",\"answer\":\"pmCiC expression in cancer cells and cancer-associated stroma correlates with tumour stage, increasing at later development stages, especially at metastatic sites.\"},{\"question\":\"Why is extracellular citrate important for cancer cells in this context?\",\"answer\":\"Extracellular citrate supports cancer cell metabolism, including fatty acid synthesis, mitochondrial activity, protein synthesis, and histone acetylation, and can promote a metastatic phenotype.\"}]","Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness | PDF",1790009112,28]